Purchase Order 75N94022P00641
- Not listed
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $8,561.32 firm fixed-price purchase order is for the delivery of DNA purification kits, with a completion date of July 16, 2012. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The $9,445.00 firm fixed-price contract does not have a set-aside designation. The contract supports NIAID's biomedical research, public health, and healthcare programs through the provision of Qiagen's sample and assay technologies, including...
- This is a $22,536 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract is for IPA (Ingenuity Pathway Analysis) software licenses and LCL (local community) group licenses. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research, and has held numerous federal...
- This federal contract award is for Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V., to provide bio-material products to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) Call with a ceiling value of $16,855.44 and a firm fixed price. Qiagen has provided products and services to various federal agencies in the past, such as DNA/RNA...
- This is a $16,800 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for NIDDK to acquire 1,000 QCII Translational biospecimen samples. Qiagen provides a wide range of molecular diagnostics products, services, and instrumentation to federal agencies, including the Department of Health and Human Services, Department of Defense,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $32,995.00, is to provide Ingenuity Variant Analysis software and services in support of the agency's biomedical research programs. Qiagen, a provider of sample and assay technologies, has a history of providing products and...
- This federal contract award is for the renewal of Qiagen's Ingenuity Pathway Analysis (IPA) software by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the Department of Health and Human Services. The $23,816 firm fixed-price purchase order has a completion date of September 22, 2022. Qiagen, a multinational biotechnology company, is the prime contractor. This award is not associated with a set-aside program. Qiagen has provided a range of products...
- This federal contract award to Qiagen, LLC, a division of Qiagen N.V., involves the delivery of RT2 Profiler Array Kits and qPCR Mastermix. The $15,087.20 fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). Qiagen is an international biotechnology company that provides a range of sample and assay technologies, including products and services supporting biomedical...
- This contract award is for the purchase of QIAGEN KITS from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $14,673.60 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS). This purchase order contract does not have a set-aside designation. Qiagen provides a range of sample and assay technologies, including DNA/RNA extraction kits,...
- This federal contract award with ID HHSN272201300990P was made to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has a firm fixed price of $2,472.73, is for maintenance services and other functions. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS). Qiagen, as a provider of sample and assay technologies for molecular diagnostics, has...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the biotechnology firm Qiagen N.V. The $28,358.00 firm fixed-price purchase order is for Intergovernmental Personnel Act (IPA) services during the period of September 29, 2022 to September 28, 2023. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research, and has a history of federal contract awards to support biomedical research, public health, and law enforcement programs across multiple agencies including HHS, the Department of Veterans Affairs, and the Department of Defense. The contract has no set-aside designation, reflecting Qiagen's status as a large, international corporation. In addition to this specific award, Qiagen holds several indefinite delivery vehicles with federal agencies to enable efficient procurement of its specialized products and services on a recurring basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 8/12/22 |